Small-molecule polypeptide, application thereof and medicine for inducing spawning and promoting activity of coilia ectenes

Through transcriptome sequencing and chemical synthesis of 12 amino polypeptide drugs of Kisspeptin2 gene, the problem of artificial induction of labor and induced stress response of knife fish was solved, and efficient ovarian maturation and ovulation were achieved, which significantly improved the survival rate and survival of induced fish. Rate.

CN118994313AActive Publication Date: 2024-11-22SHANGHAI OCEAN UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410871434.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-01
Publication Date
2024-11-22
Estimated Expiration
2044-07-01

AI Technical Summary

Technical Problem

Existing fish induced fertilization drugs are poor in different fish, especially the high mortality rate after induced induced fertilization in artificial breeding of blade fish, and there are few active-activating drugs for induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced induced

Method used

Through transcriptome sequencing technology, the Kisspeptin2 gene that is significantly differentially expressed in the ovary of the knife fish was discovered and synthesized, and 12 amino polypeptide drugs were prepared. Chemical synthesis methods were used and thoracic injections were used to improve the ovary maturation and ovulation rate of the knife fish was increased and the postpartum mortality rate was reduced.

Benefits of technology

It effectively promotes the maturation and ovulation of ovaries of knife fish, significantly improves the survival rate of fish inducing labor, and improves the efficiency and survival rate of artificial inducing labor, especially at the dose of 0.5μg/g, the induced labor rate reaches 77.8%, and the survival rate reaches 90%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118994313A_ABST
    Figure CN118994313A_ABST
Patent Text Reader

Abstract

The invention relates to the field of fish breeding, and discloses a medicine for inducing spawning and promoting survival of coilia saury, which is a polypeptide medicine obtained by chemically synthesizing a koumine gene found in a coilia saury brain transcriptome. According to the technical scheme, a transcriptome sequencing technology is combined with a biological information analysis technology, polypeptide drugs of amino groups of Kisspeptin 2 genes are found and synthesized, through fish body thoracic injection, coilia ectenes ovary maturation and ovulation can be effectively promoted, and meanwhile the survival rate of induced spawning fishes is increased.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of fish breeding, in particular to a medicine for inducing spawning and promoting survival of knife fish. Background Art

[0002] Fish breeding includes natural breeding and artificial breeding. Natural breeding is a process of mating, spawning, fertilization and hatching of fish in a natural state. For those fish that cannot estrus and spawn naturally, artificial breeding is needed. The commonly used induced ovulation drugs for artificial breeding of fish mainly include human chorionic gonadotropin (HCG), luteinizing hormone releasing hormone analog (LRH-A), pituitary gonadotropin (GtH), diothiocarbone (DOM) and different mixed preparations of these drugs. Practice has proved that different fish have different breeding conditions and gonadal development characteristics. The current drugs are effective for inducing ovulation in some fish, but not for other fish. In addition, some fish with violent temperaments, after artificial induction of ovulation, due to stress response, the fish that have not ovulated after induction of ovulation die in large numbers. For precious fish that cause a large number of deaths due to induced ovulation, it is necessary to develop new drugs with high induced ovulation efficiency, low mortality and normal spawning.

[0003] Knife fish, also known as knife anchovy, is known as one of the "Three Fresh Foods of the Yangtze River" along with pufferfish and shad for its tender meat and high nutritional value. Knife fish die when out of water, and it is difficult to catch fresh, mature knife fish for breeding. The best way is to draw water from the Yangtze River into the pond during the breeding season, and the wild knife anchovy fry will enter the pond with the water, and then catch the wild knife anchovy for breeding, and then breed naturally in the pond. Although it has been developed for more than ten years, artificially raised knife anchovy show obvious asynchrony of group gonad development. Only a small number of fish can mature their gonads and spawn naturally during the breeding season, but the yield is low, which seriously hinders the development of the knife fish industry.

[0004] Kisspeptin is a neuropeptide that acts through the G protein-coupled receptor GPR54 and is closely related to reproduction. It regulates the secretion of GnRH in reproduction and regulates the positive and negative feedback of estrogen to participate in the reproductive development process. Kisspeptin neurons regulate the positive feedback of estradiol by expressing estrogen receptor α and transmitters such as tyrosine hydroxylase, γ-aminobutyric acid and glutamate; they affect follicular development by upregulating ovarian anti-Mullerian hormone and downregulating the expression of FSH receptor (FSHR). As a key regulatory factor, kissspeptin regulates female follicular development, oocyte maturation and ovulation in many aspects. At present, drugs for inducing ovarian follicles and promoting activation after induced ovarian stress are very rare, and no research reports have been seen. Summary of the invention

[0005] In view of the defects in the prior art, the object of the present invention is to provide a medicine for inducing labor and promoting survival of knife fish.

[0006] To achieve the above purpose, the technical solution adopted by the present invention is: a drug for inducing labor and promoting survival of knife fish, wherein the drug is an amino polypeptide drug prepared by chemical synthesis from the kiss peptide gene found in the brain transcriptome of knife fish.

[0007] A technical solution of the present invention is a small molecule polypeptide, the amino acid sequence of which contains the amino acid sequence shown in SEQ ID No. 1: SEFNINPFGLRF.

[0008] Furthermore, the small molecule polypeptide consists of the sequence shown in SEQ ID NO.1.

[0009] Furthermore, the small molecule polypeptide has an amino terminal protecting group and / or a carboxyl terminal protecting group.

[0010] The amino terminal protecting group is selected from an optionally substituted C1-C10 acyl group or an optionally substituted C1-C10 amide group.

[0011] The carboxyl terminal protecting group is selected from an optionally substituted C1-C10 acyl group or an optionally substituted C1-C10 amide group.

[0012] The above-mentioned small molecule peptide can effectively promote the ovarian maturation and ovulation of knife fish, and at the same time improve the survival rate of induced spawning fish.

[0013] Another technical solution of the present invention is an isolated polynucleotide selected from one of the following groups:

[0014] (a) a polynucleotide encoding a small molecule polypeptide having an amino acid sequence as shown in SEQ ID NO.1 or a fragment, analog or derivative thereof;

[0015] (b) a polynucleotide complementary to the polynucleotide (a);

[0016] Or, (c) a polynucleotide at least 70% identical to (a) or (b).

[0017] The carboxyl terminal protecting group is selected from an optionally substituted C2-10 acyl group or an optionally substituted C2-10 amide group.

[0018] The above small molecule polypeptide can be used to prepare fish medicine. Preferably, the fish medicine is used for knife fish.

[0019] The applicable diseases of the fish medicine are inducing labor, promoting activation after inducing labor stress reaction or diseases related to abnormal secretion of female hormones.

[0020] A fish medicine, the active ingredients of which include the above-mentioned small molecule polypeptide, is a knife fish spawning and stimulating drug.

[0021] The preparation method of the fish medicine comprises the following steps: using transcriptome sequencing technology to analyze genes (DEGs) that are significantly differentially expressed in phase IV and phase II of knife fish ovarian development in the same breeding period, screening DEGs that regulate ovarian development, and identifying the CDS sequence of the kisspeptin2 gene. The 12-amino polypeptide of the kisspeptin2 gene is chemically synthesized with a purity of >90, dissolved in 0.75% Nacl physiological saline to prepare an injection solution, and the sample is injected into the thoracic cavity for induced labor.

[0022] The advantages of the present invention are:

[0023] By combining transcriptome sequencing technology with bioinformatics analysis technology, we discovered and synthesized a 12-amino peptide drug of the kisspeptin2 gene. By injecting it into the thoracic cavity of fish, it can effectively promote the maturation of the ovaries and ovulation of knife fish, while also improving the survival rate of induced spawning fish. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 The anatomical morphological characteristics of the ovaries of the 0.1 μg / g injection group (A), 0.5 μg / g injection group (B) and control group (C);

[0025] Figure 2 Shows the hormone levels in the serum of knife fish injected with different concentrations of chemically synthesized kiss peptide. DETAILED DESCRIPTION

[0026] The present invention is described in detail below in conjunction with specific embodiments. The following embodiments will help those skilled in the art to further understand the present invention, but are not intended to limit the present invention in any form. It should be noted that, for those of ordinary skill in the art, several changes and improvements can also be made without departing from the concept of the present invention. These all belong to the protection scope of the present invention.

[0027] The experimental methods in the following examples without specifying specific conditions are selected according to conventional methods and conditions, or according to the product specifications. The reagents and raw materials used in the present invention are all commercially available.

[0028] The present invention will be further described below in conjunction with embodiments:

[0029] Example 1

[0030] 1 Experimental design:

[0031] The invention analyzes significantly differentially expressed genes in two different developmental phases of knife fish ovaries during the breeding period, screens the CDS of kiss peptide genes, predicts the amino acid sequence and functional motif encoded by the CDS, chemically synthesizes the peptide chain of the functional motif, dissolves it with DMSO, dilutes it with 0.75% saline, injects it into the chest cavity, extracts blood 14 hours later, and dissects and removes the ovaries. The ELISA kit is used to detect the levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), gonadotropin-releasing hormone (GnRH) and estradiol (E2) hormones in serum.

[0032] 1.1 Experimental Materials:

[0033] During the breeding period of knife fish in mid-April, 30 adult knife fish were purchased from a farm in Jiangsu Province, weighing 66g-131.6g and with a body length of 26-31.5cm. They were randomly divided into 3 groups, with 10 fish in each group. After drug injection, they were placed in an indoor cement pool (5m×10m×1.2m) for temporary rearing.

[0034] 1.2 Drug synthesis and preparation

[0035] The 12-amino peptide of kiss peptide was chemically synthesized by Beijing Qingke Biotechnology Co., Ltd. with a purity of >90. It was first dissolved in DMSO and then prepared into an injection solution with 0.75% NaCl saline.

[0036] The sequence is: SEFNINPFGLRF-CONH2.

[0037] 1.3 Injection method and dosage

[0038] The drugs were injected intrathoracically at doses of 0.1 μg / g and 0.5 μg / g, respectively. The control group was injected with 0.75% NaCl saline.

[0039] 2 Experimental results

[0040] 2.1 Observation of ovarian development

[0041] 14 hours after the injection, the experimental fish were anesthetized with Yulebao (MS-222), 0.5 ml of blood was drawn from the tail vein, and sodium heparin was added for storage. First, a transverse incision was made at the anus, and then the abdomen was cut from the anus to the head along the midline, and the ovaries were removed for observation.

[0042] Observation results see Figure 1 . Figure 1 The anatomical morphological characteristics of the ovaries of the 0.1μg / g injection group (A), 0.5μg / g injection group (B) and control group (C)

[0043] like Figure 1As shown, 14 hours after the injection of the drug in different injection groups, 8 fish survived in the 0.1 μg / g injection group, of which 5 samples had full ovaries, blue-gray, and eggs visible to the naked eye, which was in the late stage of IV (see Figure 1 A).

[0044] like Figure 1 As shown in B, the ovaries of 3 samples were flesh-colored, and the ovules were visible to the naked eye, indicating the late stage of stage III. Among the 9 samples in the 0.5ug / g injection group, 7 samples had very full ovaries, which were jade green, and the ovules filled the ovaries, which were clearly identifiable, and free ovules were visible, indicating the early stage of stage V.

[0045] like Figure 1 As shown in C, the ovaries of 3 samples were in the late stage IV. There were 6 surviving in the control group, of which 1 sample had an early stage V ovary and 5 samples had a late stage III ovary development ( Figure 1 C). It can be seen that the artificial induction rate under the condition of 0.5ug / g drug injection is 77.8%.

[0046] 2.2 Determination of serum hormone concentrations

[0047] The blood drawn from the tail vein was centrifuged at 2000rpm for 3min, and the supernatant was taken. The levels of LH, FSH, GnRH, and E2 hormones in the serum of the experimental fish were measured using Mlbio's fish luteinizing hormone (LH) ELISA kit (ml003456-48T), fish follicle-stimulating hormone (FSH) ELISA kit (Mlbio, ml003455-48T), fish gonadotropin-releasing hormone (GnRH) ELISA kit (ml003465-48T), and fish estradiol (E2) ELISA kit (Mlbio, ml003452-48T) on a light absorption full-wavelength microplate reader (Readmax1900).

[0048] Related results can be found in Figure 2 And Table 1. Table 1 shows the hormone levels in knife fish serum and the statistics of inter-group differences.

[0049] Table 1.

[0050]

[0051] In Table 1, *: significant difference (P < 0.05); **: extremely significant difference (P < 0.01)

[0052] Figure 2 The hormone levels in the serum of knife fish in the injection groups of chemically synthesized kiss peptide at different concentrations are shown. The four sub-graphs A, B, C and D respectively represent the hormone levels of LH, FSH, E2 and GnRHd. The injection doses of each sub-graph can be found in Table 1. Figure 2In the table, *: significant difference (P < 0.05); **: extremely significant difference (P < 0.01); ns: no significant difference

[0053] Combining Table 1 and Figure 2 It can be seen that compared with the control group, the LH content in the 0.1μg / g injection group and the 0.5μg / g injection group increased significantly (P<0.05); although the FSH, GnRH and E2 contents increased, only the 0.5μg / g injection group showed a significant (P<0.05) or extremely significant (P<0.01) increase. The increase in serum LH, FSH, GnRH and E2 hormone levels was drug dose-dependent, and the effective dose of chemically synthesized kiss peptide drugs for artificial induction of spawning of Coilia scaly was 0.5μg / g.

[0054] As shown in Table 1, the number of experimental fish in the 0.1ug / g injection group, the 0.5ug / g injection group, and the control group was 10 at the beginning. After 14 hours of temporary storage, the number of surviving experimental fish was 8, 9, and 6, respectively, and the survival rates were 80%, 90%, and 60%, respectively. It can be seen that the drug can significantly improve the survival rate of experimental fish while artificially inducing labor.

[0055] From the above, it can be seen that the knife fish kiss peptide, as an induced labor drug, affects the ovarian maturation and survival of knife fish after induced labor, and the small molecule polypeptide prepared in this case also has relevant activity, which can be used in the reproduction, induced labor and survival promotion of knife fish, especially it can effectively induce artificial labor of knife fish and improve the survival rate of knife fish during the induced labor process.

[0056] It should be noted that the prior art in the protection scope of the present invention is not limited to the embodiments given in the present application documents. All prior art that does not contradict the scheme of the present invention, including but not limited to prior patent documents, prior public publications, prior public uses, etc., can be included in the protection scope of the present invention.

[0057] In addition, the combination of the various technical features in this case is not limited to the combination described in the claims of this case or the combination described in the specific embodiments. All technical features recorded in this case can be freely combined or combined in any way unless there is a contradiction between them.

[0058] The above describes the specific embodiments of the present invention. It should be understood that the present invention is not limited to the above specific embodiments, and those skilled in the art can make various changes or modifications within the scope of the claims, which does not affect the essence of the present invention. In the absence of conflict, the embodiments of the present application and the features in the embodiments can be combined with each other arbitrarily.

Claims

1. A small molecule polypeptide, characterized in that: The amino acid sequence of the small molecule polypeptide contains the amino acid sequence shown in SEQ ID No.

1.

2. The small molecule polypeptide according to claim 1, characterized in that: The small molecule polypeptide consists of the sequence shown in SEQ ID NO.

1.

3. The small molecule polypeptide according to claim 1 or 2, characterized in that: The small molecule polypeptide has an amino terminal protecting group and / or a carboxyl terminal protecting group.

4. The small molecule polypeptide according to claim 3, characterized in that: The amino terminal protecting group is selected from an optionally substituted C1-C10 acyl group or an optionally substituted C1-C10 amide group.

5. The small molecule polypeptide according to claim 3, characterized in that: The carboxyl terminal protecting group is selected from an optionally substituted C1-C10 acyl group or an optionally substituted C1-C10 amide group.

6. An isolated polynucleotide characterized in that The polynucleotide comprises one selected from the group consisting of: (a) a polynucleotide encoding a small molecule polypeptide having an amino acid sequence as shown in SEQ ID NO.1 or a fragment, analog or derivative thereof; (b) a polynucleotide complementary to the polynucleotide (a); Or, (c) a polynucleotide at least 70% identical to (a) or (b).

7. Use of the small molecule polypeptide as described in claims 1 to 5 in the preparation of fish medicine.

8. The use according to claim 7, characterized in that: The applicable diseases of the fish medicine are inducing labor, promoting activation after inducing labor stress reaction or diseases related to abnormal secretion of female hormones.

9. The use according to claim 7, characterized in that: The fish medicine is used for knife fish.

10. A fish medicine, characterized in that: The active ingredient of the fish medicine includes the small molecule polypeptide as described in any one of claims 1 to 5.

Citation Information

Patent Citations

  • Kaleic peptides for predicting and treating delays in puberty

    CN114599385A

  • Reproduction of fish by induced spawning with an injection containing both buserelin and domperidone

    WO2019049163A1